
EASD 2025
Efficacy and Tolerance of SGLT2 Inhibitors in Patients with Prader-Willi Syndrome and Type 2 Diabetes
A groundbreaking French study has provided the first comprehensive evidence

A groundbreaking French study has provided the first comprehensive evidence

Researchers have developed a groundbreaking artificial intelligence system called DiabetAid

A comprehensive analysis of over 74,000 patients with type 2

Italian researchers presented compelling evidence today at the 61st European

A comprehensive real-world study presented at the 61st European Association

A comprehensive analysis from the STEP UP trial presented at